Chugai Pharma just released some broken down sales data of Tamiflu (which I previously had to use an arbitrary split between seasonal and stockpiling for my graph). It changes the sales data a bit between seasonal and stockpiling.
The graph has been updated for seasonal market... it means Tamiflu's sales increased 5.7 fold, not 8 compared to prior quarter or 2x compared to same time last year... so if we track those increases it is still a healthy number.
Have to emphasis again it still is a pie in the sky estimate.
- Forums
- ASX - By Stock
- BTA
- Ann: Relenza March Quarter Royalty
Ann: Relenza March Quarter Royalty , page-26
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online